Literature DB >> 6298406

Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release.

M Raiteri, G Maura, P Versace.   

Abstract

The effects of norepinephrine and of various alpha adrenoceptor antagonists on the depolarization-evoked release of norepinephrine and 5-hydroxytryptamine were studied in nerve terminals isolated from rat cerebral cortex, preincubated with the radioactive amines and exposed during superfusion to 15 mM KCI. Exogenous norepinephrine inhibited in a concentration-dependent way both the release of norepinephrine and that of serotonin. The inhibitory effect of norepinephrine was antagonized by yohimbine and mianserin, but not by prazosin, indicating the involvement of alpha-2 adrenoceptors. The two enantiomers of mianserin were examined as alpha-2 adrenoceptor antagonists in the two release systems. Only (+)-mianserin was an effective antagonist at the alpha-2 autoreceptors mediating regulation of norepinephrine release; (-)-mianserin was inactive. In contrast, both enantiomers antagonized exogenous norepinephrine at the alpha-2 adrenoceptors regulating 5-hydroxytryptamine release. It can be concluded that the alpha-2 adrenoceptors which regulate, respectively, norepinephrine and serotonin release in the cerebral cortex are located on presynaptic nerve terminals and represent two stereochemically different subtypes of alpha-2 adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298406

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  24 in total

1.  Acute and chronic effects of the atypical antidepressant, mianserin on brain noradrenergic neurons.

Authors:  A L Curtis; R J Valentino
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  The role of the central noradrenergic system in behavioral inhibition.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res Rev       Date:  2011-03-05

3.  Neurochemical evidence for two types of presynaptic alpha 2-adrenoceptors.

Authors:  J Kapocsi; G T Somogyi; N Ludvig; P Serfozo; L G Harsing; R J Woods; E S Vizi
Journal:  Neurochem Res       Date:  1987-02       Impact factor: 3.996

4.  Thyroid hormone and norepinephrine: effects on alpha-2, beta, and reuptake sites in cerebral cortex and heart.

Authors:  A C Swann
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

5.  Bidirectional pharmacological perturbations of the noradrenergic system differentially affect tactile detection.

Authors:  Jim McBurney-Lin; Yina Sun; Lucas S Tortorelli; Quynh Anh T Nguyen; Sachiko Haga-Yamanaka; Hongdian Yang
Journal:  Neuropharmacology       Date:  2020-05-21       Impact factor: 5.250

6.  Neurochemical correlates of behavioural responses to frustrative nonreward in the rat: implications for the role of central noradrenergic neurones in behavioural adaptation to stress.

Authors:  S C Stanford; P Salmon
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

7.  The alpha 2-adrenoceptors of the human retinoblastoma cell line (Y79) may represent an additional example of the alpha 2C-adrenoceptor.

Authors:  M M Gleason; J P Hieble
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

8.  Presynaptic alpha 2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different alpha 2-adrenoceptor subtypes.

Authors:  G Maura; G Bonanno; M Raiteri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

9.  In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus.

Authors:  R Mongeau; P Blier; C de Montigny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

10.  Effects of alpha 2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)-treated rats.

Authors:  G Engberg; E Eriksson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.